Filing Details
- Accession Number:
- 0001209191-12-038757
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-07-20 17:04:14
- Reporting Period:
- 2012-02-16
- Filing Date:
- 2012-07-20
- Accepted Time:
- 2012-07-20 17:04:14
- Original Submission Date:
- 2012-02-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454240 | Joseph John Feeney | 2200 Pennsylvania Avenue Suite 300E Washington DC 20037 | Svp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-16 | 7,500 | $0.00 | 12,015 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-02-16 | 4,687 | $0.00 | 16,702 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-16 | 4,760 | $4.65 | 11,942 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 15,000 shares.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 19,687 shares.
- This transaction was executed in multiple trades at prices ranging from $4.62 to $4.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 14,927 shares.
Billionaire Hedge Funds
